Current Roles

Employees:
336
Revenue:
$94.6M
About
Cerevel Therapeutics is a biopharmaceutical company focused on developing new therapies to treat disorders of the central nervous system (CNS). The company has a portfolio of experimental neuroscience therapies, which include three clinical-stage compounds and several pre-clinical compounds designed to target a broad range of CNS disorders, including Parkinsonᅢᄁ¬ツᆲ¬トᄁs, Alzheimerᅢᄁ¬ツᆲ¬トᄁs, epilepsy, schizophrenia and addiction. Headquartered in the Greater Boston area, Cerevel was formed in 2018 through a partnership between Bain Capital and Pfizer.
Cerevel Therapeutics Address
222 Jacobs Street
Boston, MA
United States
Cerevel Therapeutics Email

Past Companies

Cerevel TherapeuticsVice President
PfizerHead of Portfolio Technologies & External Opportunities, Internal Medicine Research Unit
PfizerExecutive Director

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.